Iα52
Need Assistance?
  • US & Canada:
    +
  • UK: +

Iα52

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Iα52 is a naturally processed peptide containing 52-68 residues of the mouse I-Eα chain that may contribute to the selection of immature T cells.

Category
Others
Catalog number
BAT-009266
CAS number
137756-45-7
Molecular Formula
C73H118N20O25
Molecular Weight
1675.84
Iα52
IUPAC Name
(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,35S,38S,41S)-20-(2-amino-2-oxoethyl)-35-(3-amino-3-oxopropyl)-5-(4-aminobutyl)-41-((S)-2-((S)-2-((S)-2-aminopropanamido)-3-hydroxypropanamido)-3-phenylpropanamido)-17-((S)-sec-butyl)-8-(carboxymethyl)-26-isobutyl-11-isopropyl-2,14,23,29,38-pentamethyl-4,7,10,13,16,19,22,25,28,31,34,37,40-tridecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazatetratetracontanedioic acid
Synonyms
L-Alanine, L-alanyl-L-seryl-L-phenylalanyl-L-α-glutamyl-L-alanyl-L-glutaminylglycyl-L-alanyl-L-leucyl-L-alanyl-L-asparaginyl-L-isoleucyl-L-alanyl-L-valyl-L-α-aspartyl-L-lysyl-; L-Alanyl-L-seryl-L-phenylalanyl-L-α-glutamyl-L-alanyl-L-glutaminylglycyl-L-alanyl-L-leucyl-L-alanyl-L-asparaginyl-L-isoleucyl-L-alanyl-L-valyl-L-α-aspartyl-L-lysyl-L-alanine; Ala-Ser-Phe-Glu-Ala-Gln-Gly-Ala-Leu-Ala-Asn-Ile-Ala-Val-Asp-Lys-Ala
Purity
≥95%
Density
1.301±0.06 g/cm3
Boiling Point
2049.5±65.0°C at 760 mmHg
Sequence
ASFEAQGALANIAVDKA
Storage
Store in a cool and dry place and at 2-8°C for short term (days to weeks) or store at -20°C for long term (months to years)
Solubility
Soluble in DMSO
InChI
InChI=1S/C73H118N20O25/c1-13-35(6)57(72(116)82-40(11)62(106)92-56(34(4)5)71(115)90-49(30-55(100)101)68(112)85-43(21-17-18-26-74)64(108)83-41(12)73(117)118)93-69(113)48(29-52(77)96)88-61(105)39(10)81-66(110)46(27-33(2)3)87-59(103)37(8)79-53(97)31-78-63(107)44(22-24-51(76)95)84-60(104)38(9)80-65(109)45(23-25-54(98)99)86-67(111)47(28-42-19-15-14-16-20-42)89-70(114)50(32-94)91-58(102)36(7)75/h14-16,19-20,33-41,43-50,56-57,94H,13,17-18,21-32,74-75H2,1-12H3,(H2,76,95)(H2,77,96)(H,78,107)(H,79,97)(H,80,109)(H,81,110)(H,82,116)(H,83,108)(H,84,104)(H,85,112)(H,86,111)(H,87,103)(H,88,105)(H,89,114)(H,90,115)(H,91,102)(H,92,106)(H,93,113)(H,98,99)(H,100,101)(H,117,118)/t35-,36-,37-,38-,39-,40-,41-,43-,44-,45-,46-,47-,48-,49-,50-,56-,57-/m0/s1
InChI Key
TXMLYGXMVXCTJG-JCKKSCIOSA-N
Canonical SMILES
O=C(O)CCC(NC(=O)C(NC(=O)C(NC(=O)C(N)C)CO)CC=1C=CC=CC1)C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)C)CCCCN)CC(=O)O)C(C)C)C)C(C)CC)CC(=O)N)C)CC(C)C)C)CCC(=O)N)C
1. In the normal repertoire of CD4+ T cells, a single class II MHC/peptide complex positively selects TCRs with various antigen specificities
B Chmielowski, P Muranski, L Ignatowicz J Immunol. 1999 Jan 1;162(1):95-105.
In the thymus, immature T cells are positively and negatively selected by multiple interactions between their Ag receptors (TCRs) and self MHC/peptide complexes expressed on thymic stromal cells. Here we show that in the milieu of negative selection on physiological self class II MHC/peptide complexes (Abwt), a single class II/peptide complex AbEp52-68 positively selects a number of TCRs with various Ag specificities. This TCR repertoire is semidiverse and not biased toward Ep-like Ags. Our finding implies that the degeneracy of positive selection for peptide ligands exceeds peptide-specific negative selection and is essential to increase the efficiency and diversity of the repertoire so that T cells with the same Ag specificity can be selected by different self MHC/ peptide complexes.
2. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells
Dirk M Zajonc, Mitchell Kronenberg Immunol Rev. 2009 Jul;230(1):188-200. doi: 10.1111/j.1600-065X.2009.00802.x.
Most T lymphocytes recognize peptide antigens bound to or presented by molecules encoded in the major histocompatibility complex (MHC). The CD1 family of antigen-presenting molecules is related to the MHC-encoded molecules, but CD1 proteins present lipid antigens, mostly glycolipids. Here we review T-lymphocyte recognition of glycolipids, with particular emphasis on the subpopulation known as natural killer T (NKT) cells. NKT cells influence many immune responses, they have a T-cell antigen receptor (TCR) that is restricted in diversity, and they share properties with cells of the innate immune system. NKT cells recognize antigens presented by CD1d with hexose sugars in alpha-linkage to lipids, although other, related antigens are known. The hydrophobic alkyl chains are buried in the CD1d groove, with the carbohydrate exposed for TCR recognition, together with the surface of the CD1d molecule. Therefore, understanding the biochemical basis for antigen recognition by NKT cells requires an understanding of how the trimolecular complex of CD1d, glycolipid, and the TCR is formed, which is in part a problem of carbohydrate recognition by the TCR. Recent investigations from our laboratories as well as studies from other groups have provided important information on the structural basis for NKT-cell specificity.
3. Diverse fine specificity and receptor repertoire of T cells reactive to the major VP1 epitope (VP1230-250) of Theiler's virus: V beta restriction correlates with T cell recognition of the c-terminal residue
B S Kim, Y Y Bahk, H K Kang, R L Yauch, J A Kang, M J Park, N M Ponzio J Immunol. 1999 Jun 15;162(12):7049-57.
Theiler's murine encephalomyelitis virus induces chronic demyelinating disease in genetically susceptible mice. The histopathological and immunological manifestation of the disease closely resembles human multiple sclerosis, and, thus, this system serves as a relevant infectious model for multiple sclerosis. The pathogenesis of demyelination appears to be mediated by the inflammatory Th1 response to viral epitopes. In this study, T cell repertoire reactive to the major pathogenic VP1 epitope region (VP1233-250) was analyzed. Diverse minimal T cell epitopes were found within this region, and yet close to 50% of the VP1-reactive T cell hybridomas used V beta 16. The majority (8/11) of the V beta 16+ T cells required the C-terminal amino acid residue on the epitope, valine at position 245, and every T cell hybridoma recognizing this C-terminal residue expressed V beta 16. However, the complementarity-determining region 3 sequences of the V beta 16+ T cell hybridomas were markedly heterogeneous. In contrast, such a restriction was not found in the V alpha usage. Only restricted residues at this C-terminal position allowed for T cell activation, suggesting that V beta 16 may recognize this terminal residue. Further functional competition analysis for TCR and MHC class II-contacting residues indicate that many different residues can be involved in the class II and/or TCR binding depending on the T cell population, even if they recognize the identical minimal epitope region. Thus, recognition of the C-terminal residue of a minimal T cell epitope may associate with a particular V beta (but not V alpha) subfamily-specific sequence, resulting in a highly restricted V beta repertoire of the epitope-specific T cells.
Online Inquiry
Verification code
Inquiry Basket